What does ROAD stand for?

Reversible Obstructive Airway Disease

This definition appears very rarely and is found in the following Acronym Finder categories:

Science, medicine, engineering, etc.

Other Resources:

<< Previous	Abbreviation Database Surfer		Next >>
Royal Army Ordnance Corps (Netherlands) Russian Orthodox Autonomous Church Rental Owners Association of Columbia County (Oregon) Returns on Average Capital Employed Radiology, Ophthalmology, Anesthesiology and Dermatology Reading Opens All Doors Rebel Outlaw Autoduelists (gaming) Recherche Opérationnelle et Aide à la Décision (French) Reorganization Objective Army Divisions Retired On Active Duty		Roadway Express (stock symbol) Rural Ontario Anarchist Development (Canada) Rospa Advanced Drivers' Association (UK) Rental Owners Association of Douglas County (Roseburg, OR) Royal Oak Area Democratic Club (Royal Oak, MI) Road Clearance Request Road Clearance Response Recherche Opérationnelle et d'Aide à la Décision Société Française de Recherche Opérationnelle et d'Aide À La Décision Réseau des Organisations et des Associations de Défense des Droits de l'Homme (French: Network Organizations and Associations for the Defense of Human Rights)

Samples in periodicals archive:

DAVA's sample request letter, however, promotes the use of VoSpire ER, which it says it's "specially formulated to maintain plasma levels in patients with reversible obstructive airway disease by utilizing a controlled release of albuterol sulfate" and also is "indicated for the relief of bronchospasm in adults and children 6 years of age and older.

DAVA Pharmaceuticals, Inc., Fort Lee, NJ, Sept. 21, (DDMAC)

XOPENEX(R) brand levalbuterol HCl Inhalation Solution - Marketed through Sepracor's sales force, XOPENEX Inhalation Solution is a short-acting bronchodilator indicated for the treatment or prevention of bronchospasm in patients 6 years of age and older with reversible obstructive airway disease, such as asthma.

SEPRACORE REPORTS NET INCOME OF $11.3 MIL FOR 2ND QTR 2006

Food and Drug Administration (FDA) has approved Xopenex[R] brand levalbuterol HCI inhalation solution for the treatment or prevention of bronchospasm in children 6 to 11 years old with reversible obstructive airway disease, such as asthma.

Inhalation solution approved for bronchospasm in children. (Product ...

Sepracor's sales force has marketed XOPENEX brand levalbuterol HCl Inhalation Solution, which is a short-acting beta-agonist indicated for the treatment or prevention of bronchospasm in patients six years of age and older with reversible obstructive airway disease, since 1999.

BROVANA(TM) Inhalation Solution Now Available by Prescription for ...

ProAir([R]) HFA is indicated in adults and children 12 years of age and older for the treatment or prevention of bronchospasm with reversible obstructive airway disease and for the prevention of exercise-induced bronchospasm.

Teva Partners with Asthma Foundation and NBA to Go Pro for Asthma ...

XOPENEX HFA is indicated for treatment or prevention of bronchospasm in adults, adolescents and children 4 years of age and older with reversible obstructive airway disease.

XOPENEX HFA(R) Data Presented at American College of Allergy, Asthma ...

XOPENEX HFA is indicated for the treatment or prevention of bronchospasm in adults, adolescents and children 4 years of age and older with reversible obstructive airway disease.

XOPENEX HFA(R) Data to Be Presented at American College of Allergy, ...

XOPENEX([R]) brand levalbuterol HCl Inhalation Solution - XOPENEX Inhalation Solution is a short-acting bronchodilator indicated for the treatment or prevention of bronchospasm in patients 6 years of age and older with reversible obstructive airway disease, such as asthma.

Sepracor Announces Third Quarter 2006 Operating Results